Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$4.98 USD
+0.29 (6.18%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.98 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | 0.12 |
EPS Last Quarter | 0.00 |
Last EPS Surprise | -100.00% |
ABR | 1.33 |
Earnings ESP
|
-13.04% |
---|---|
Current Year | 0.36 |
Next Year | 0.48 |
EPS (TTM) | 0.10 |
P/E (F1) | 13.93 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 94.72M | 99.97M | 354.80M | 367.37M |
# of Estimates | 4 | 4 | 3 | 4 |
High Estimate | 108.16M | 115.67M | 363.00M | 436.69M |
Low Estimate | 88.50M | 89.50M | 350.30M | 290.00M |
Year ago Sales | 113.74M | 117.55M | 442.73M | 354.80M |
Year over Year Growth Est. | -16.73% | -14.96% | -19.86% | 3.54% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.12 | 0.17 | 0.36 | 0.48 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | 0.05 | 0.07 | 0.10 | 0.26 |
High Estimate | 0.18 | 0.36 | 0.73 | 0.70 |
Low Estimate | 0.05 | 0.07 | 0.10 | 0.26 |
Year ago EPS | 0.12 | 0.00 | -6.27 | 0.36 |
Year over Year Growth Est. | 0.00% | NA | 105.74% | 34.03% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 3 | 4 | 4 |
Down Last 60 Days | 3 | 3 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.12 | 0.17 | 0.36 | 0.48 |
7 Days Ago | 0.12 | 0.17 | 0.36 | 0.48 |
30 Days Ago | 0.17 | 0.22 | 0.56 | 0.75 |
60 Days Ago | 0.17 | 0.22 | 0.56 | 0.75 |
90 Days Ago | 0.17 | 0.22 | 0.56 | 0.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.10 | 0.17 | 0.36 | 0.48 |
Zacks Consensus Estimate | 0.12 | 0.17 | 0.36 | 0.48 |
Earnings ESP | -13.04% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.00 | -0.02 | 0.00 | 0.12 | NA |
Estimate | 0.17 | 0.18 | 0.20 | 0.17 | NA |
Difference | -0.17 | -0.20 | -0.20 | -0.05 | -0.16 |
Surprise | -100.00% | -111.11% | -100.00% | -29.41% | -85.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more